← Home / RIGEL PHARMACEUTICALS INC (RIGL)
Stock Analysis
RIGEL PHARMACEUTICALS INC (RIGL)
RIGL
RIGL · Market data
36.81 -3.28%
Track RIGL in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when RIGL price is:
52W Range Position
53%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 50.96. Holding above 36.45 keeps the current thesis intact.
⚖️
✓
Fundamentals
Moderate / Positive
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
36.45
↗
Break Above
Confirmation improves above resistance.
50.96
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 36.45
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
1
●
Management / Board
MEDIUM
RIGL board and management update
On July 1, 2026, Rigel Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
JUN
17
●
Material Agreement
MEDIUM
RIGL material agreement
Completion of Acquisition or Disposition of Assets.
8-K Filing • SEC EDGAR
MAY
20
●
Management / Board
MEDIUM
RIGL board and management update
Approval of Equity Compensation Plans Approval of 2018 Equity Incentive Plan, As Amended On May 14, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Rigel Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
What's Driving RIGL?
📈 Technical recovery is improving
Momentum is Neutral. Watch 50.96 for confirmation and 36.45 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 36.45
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
43.38
RSI(14)
44.2
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 36.45 and resistance around 43.38. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
RIGL — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Value
Value-oriented setup
Low multiples and positive free cash flow suggest a more grounded valuation.
Market Cap
$724.6M
Company size
EV
$745.2M
Debt-adjusted value
P/E
2.0
Low multiple
P/S
2.4
Low sales multiple
P/B
1.8
Low book multiple
EV/Sales
2.5
Low sales multiple
EV/EBIT
6.0
Low multiple
P/FCF
9.2
Low multiple
FCF Yield
10.88%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving business, cash flow needs monitoring
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Positive
≈
Cash Flow
Pressured
⚖
Balance Sheet
Manageable
💵 Revenue
58.82M
≈ Moderate
📈 Net Income
8.65M
↗ Positive
🧮 EPS (Basic)
0.47
↗ Positive
RIGEL PHARMACEUTICALS INC
Related Opportunities